Axcella long COVID treatment helps some patients in small trial

In the 41-patient pilot study released on Tuesday, for three of 21 patients who received the drug, AXA1125, their physical fatigue scores returned to normal levels after 28 days of treatment, Axcella Chief Medical Officer Margaret Koziel said in a phone interview.

“This trial is suggesting that a drug that’s very safe to take and has minimal side effects is causing substantial improvement in people’s physical and cognitive experience of fatigue,” said Dr. Jason Maley, a consultant for Axcella who runs a long COVID clinic at Beth Israel Deaconess Medical Center in Boston.Article content

For the study’s primary goal, there was no statistically significant difference between the groups on phosphocreatine recovery time.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Axcella long COVID treatment helps some patients in small trialOne of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and mental fatigue, although the drug developed by Axcella Health Inc failed on the small study's main goal of restoring the normal function of mitochondria - the energy factories of cells. You know what also helps? Ivrmectin. Been around forever and even pregnant women can take it. Ignoring it is just pathetic and ridiculous Still spreading the lie that there is a deadly pandemic we should be worried about Long covid is a cover-up of vaccines side effects. So the solution is to take another medication that's equally untested and unknown?
Source: CTVNews - 🏆 1. / 99 Read more »

Axcella long COVID treatment helps some patients in small trialOne of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and mental fatigue. Brought to you by Pfi$er. Ivermectin also helps but that's not a Pfizer medication
Source: TheTorontoSun - 🏆 23. / 68 Read more »